ASHM provides leadership in health workforce and research-based policy development and supports the efforts of others relating to policy and advocacy in the sector. This work includes the development of Position Statements, in consultation with our members. If you have policy issues which you think should be brought to ASHM's attention, please email ashm@ashm.org.au

ASHM is a member of the National Blood Borne Viruses and Sexually Transmissible Infections Standing Committee (BBVSS) and contributes to the development of national , state and territory sexual health and BBV strategies and implementation/action plans.  

 

Third National Hepatitis B Strategy 2018-2020 

Endorsement of Hepatitis B management during immunosuppression for haematological and solid-organ malignancies: an Australian Consensus Statement 2018 

Hepatitis B and Immigration – a template to support clinicians who have patients with chronic hepatitis B applying for a permanent visa 

Recommendation to update the Guidelines for Preventive Activities in General Practice (Red Book) to include hepatitis B 

Submission to CDNA on National Guidelines on Infected Health Care Workers 

Second National Hepatitis B Strategy 2014-2017 

Successful submission to PBAC to allow HBV s100 GPs to initiate CHB treatment 

Position statement on Nurse Practitioner Prescribing for Section 100 Medications for the treatment of HIV and Hepatitis B and Section 85 Medications for Hepatitis C in Australia 

Submission to Australian Health Practitioner Regulation Agency (AHPRA) on National Guidelines on Infected Health Care Workers 

Endorsement of Australasian Hepatology Association (AHA) Practice Standards for the Hepatology Nurse 

Contribution to National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people 

Contribution to Protocol Advisory Sub-Committee of MSAC on protocol application for the use of Transient Elastography for Viral Hepatitis 

Letter against the introduction of mandatory BBV testing in NSW, QLD and SA 

Submission to CDNA on National Guidelines on Infected Health Care Workers 

Submission to TGA Review of Medicines and Medical Devices Regulation 

First National Hepatitis B Strategy 

Advocacy to remove liver biopsy as a requirement prior to treatment 

Advocacy on hepatitis B prescribing and dispensing 

Development of the Auckland Statement on viral hepatitis 

Contribution to MSAC application for the use of Transient Elastography for Viral Hepatitis 

 

Fifth National Hepatitis C Strategy 2018-2020 

Recommendation to update the Guidelines for Preventive Activities in General Practice (Red Book) to include hepatitis C 

Submission on simplification of HCV DAA PBS listing 

Submission to CDNA on National Guidelines on Infected Health Care Workers 

Submission to PHARMAC on pangenotypic medications for HCV 

Fourth National Hepatitis C Strategy 2014-2017 

Addition of nurse practitioner experienced in the treatment of hepatitis C to the treatment criteria in the PBS listing for HCV DAAs 

Addition of medical practitioner or an authorised nurse practitioner experienced in the treatment of chronic hepatitis C to the treatment criteria in the PBS listing for HCV DAAs 

Position statement affirming efficacy of Direct Acting Antiviral therapy for hepatitis C 

Position statement on Nurse Practitioner Prescribing for Section 100 Medications for the treatment of HIV and Hepatitis B and Section 85 Medications for Hepatitis C in Australia 

Letter of support for listing of pangenotypic HCV DAA treatments on the PBS 

Submission to PBAC on broad prescriber eligibility for HCV DAAs prior to PBS listing 

Submission and Presentation at Senate Inquiry into Hepatitis C 

Joint submission with Hepatitis Foundation New Zealand to PHARMAC on impacts of Hepatitis C treatment in New Zealand 

Submission to Australian Health Practitioner Regulation Agency (AHPRA) on National Guidelines on Infected Health Care Workers 

Endorsement of Australasian Hepatology Association (AHA) Practice Standards for the Hepatology Nurse 

Contribution to National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people 

Contribution to Protocol Advisory Sub-Committee of MSAC on protocol application for the use of Transient Elastography for Viral Hepatitis 

Letter against the introduction of mandatory BBV testing in NSW, QLD and SA 

Position statement and guidance for clinicians on importation of generic DAAs 

Submission to CDNA on National Guidelines on Infected Health Care Workers 

Submission to TGA Review of Medicines and Medical Devices Regulation 

Third National Hepatitis C Strategy 2010-2013 

Development of the Auckland Statement on viral hepatitis 

Contribution to MSAC application for the use of Transient Elastography for Viral Hepatitis 

Submission to Red Cross review of blood donations from people who inject drugs 

Eighth National HIV Strategy 2018-2020 

Undetectable=Untransmittable (U=U): a guide for clinicians 

Submission to CDNA on National Guidelines on Infected Health Care Workers 

Seventh National HIV Strategy 2014-2017 

Letter against the introduction of mandatory BBV testing in NSW, QLD and SA 

Contribution to PBAC submission for PrEP application 

Position statement on Nurse Practitioner Prescribing for Section 100 Medications for the treatment of HIV and Hepatitis B and Section 85 Medications for Hepatitis C in Australia 

Letter against mandatory BBV testing to Attorney General, Legal Aid Commission and Police Union 

Advocacy with UNAIDS on HIV and immigration  

Submission to Australian Health Practitioner Regulation Agency (AHPRA) on National Guidelines on Infected Health Care Workers 

Contribution to National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people 

Access to HIV Treatment in Australia 

Submission to TGA on HIV POCT 

Submission to CDNA on National Guidelines on Infected Health Care Workers 

Submission to TGA Review of Medicines and Medical Devices Regulation 

Sixth National HIV Strategy 2010-2013 

Successful submission to PBAC to remove CD4+ count as part of treatment criteria for HIV 

 

Fifth National Aboriginal and Torres Strait Islander Blood-Borne Viruses and Sexually Transmissible Infections Strategy 2018-2020 

Fourth National Aboriginal and Torres Strait Islander Blood-Borne Viruses and Sexually Transmissible Infections Strategy 2014-2017 

Contribution to National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people 

Letter protesting defunding of 2 Spirits programs 

Third National Aboriginal and Torres Strait Islander Blood-Borne Viruses and Sexually Transmissible Infections Strategy 2010-2013 

National Strategy feedback meeting